Dr. David B. Fittingoff, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
7345 Medical Center Dr, Suite 600
West Hills, CA 91307
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Hahnemann University College of Medicine (1973)
- Years since graduation
- 53
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 401
Licensed in California since 1974, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1973Medical school: Hahnemann University College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
CA license G27978 (first issued 1974; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UCLA West Valley Medical Center West Hills, CA
- Northridge Hospital Medical Center Northridge, CA
Medical groups
- Providence Medical Institute (288 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 401
- Services billed
- 15,973
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 3,840 | 39 |
| Established patient office or other outpatient visit, 30-39 minutes | 496 | 243 |
| Established patient office or other outpatient visit, 20-29 minutes | 374 | 221 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 173 | 78 |
| Injection of drug or substance under skin or into muscle | 111 | 45 |
| Administration of influenza virus vaccine | 64 | 61 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 63 | 60 |
| Dxa bone density measurement of hip, pelvis, spine | 54 | 54 |
| New patient office or other outpatient visit, 45-59 minutes | 36 | 36 |
| Blood glucose (sugar) test performed by hand-held instrument | 18 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in West Hills, CA | 756 |
| Metformin Hcl Other prescribers in West Hills, CA | 566 |
| Levothyroxine Sodium Other prescribers in West Hills, CA | 516 |
| Ozempic (semaglutide) Other prescribers in West Hills, CA | 488 |
| Amlodipine Besylate Other prescribers in West Hills, CA | 350 |
| Jardiance (empagliflozin) Other prescribers in West Hills, CA | 275 |
| Lisinopril Other prescribers in West Hills, CA | 238 |
| Nano 2nd Gen Pen Needle (pen needle, diabetic) Other prescribers in West Hills, CA | 219 |
| Alprazolam Other prescribers in West Hills, CA | 200 |
| Rosuvastatin Calcium Other prescribers in West Hills, CA | 164 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 26 companies reported 233 payments worth $7,794 in total to this clinician.
| Amgen Inc. | $1,311 |
|---|---|
| Dexcom, Inc. | $1,082 |
| Novo Nordisk Inc | $847 |
| Xeris Pharmaceuticals, Inc. | $656 |
| Abbott Laboratories | $637 |
| Corcept Therapeutics | $454 |
| AstraZeneca Pharmaceuticals LP | $427 |
| Mannkind Corporation | $379 |
| Food and Beverage | $7,794 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $152,066 in research payments for these studies, mostly to the institutions running them.
- A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. · Active, not recruiting · NCT06345339 - Study name not reported
Novo Nordisk As - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.